Paul Efron
Director · Keenova Therapeutics plc
Individual
- 2025
- Jul 18, 2026
- 4
Filings (90d)
0
Purchases
0
Sales
0
Summary
Latest filing:
Paul Efron has 4 SEC Form 4 filings on record going back to 2025, most recently on 18 July 2026.
Recent transactions
3The latest 3 SEC Form 4 transactions reported by Paul Efron.
Most active insiders across the market
Paul Efron has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Conifer Management, L.L.C. - $187.26M in GPI purchases and sales in the last 90 days
- David A. Duffield - $186.00M in WDAY purchases and sales in the last 90 days
- Control Empresarial de Capitales S.A. de C.V. - $177.80M in PBF purchases and sales in the last 90 days
- J.H. Whitney Equity Partners VII, LLC - $169.58M in AVAH purchases and sales in the last 90 days
- Vyacheslav Kim - $158.37M in KSPI purchases and sales in the last 90 days
- John B. Hess - $157.37M in CVX purchases and sales in the last 90 days
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul Efron?
Paul Efron is a corporate insider, tracked as Director. InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Paul Efron last file a Form 4?
The most recent primary Form 4 on record is dated 18 July 2026, one of 4 filings going back to 2025.